| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/29/2009 | CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 12/29/2009 | CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/29/2009 | CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them |
| 12/24/2009 | US20090318494 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy |
| 12/24/2009 | US20090318437 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE |
| 12/24/2009 | US20090318397 Combination of Azelastine and Steroids |
| 12/24/2009 | US20090318396 Corticosteroid linked beta-agonist compounds for use in therapy |
| 12/24/2009 | US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii |
| 12/24/2009 | US20090317477 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
| 12/24/2009 | US20090317470 Oramucosal Pharmaceutical Dosage Form |
| 12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
| 12/23/2009 | WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/23/2009 | WO2009155056A2 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 12/23/2009 | WO2009154800A2 Compositions and methods for treating lung disorders |
| 12/23/2009 | WO2009154562A1 Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity |
| 12/23/2009 | WO2009154557A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
| 12/23/2009 | WO2009154555A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist |
| 12/23/2009 | WO2009154554A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009153721A1 Nicotinamide derivatives |
| 12/23/2009 | WO2009153720A1 Nicotinamide derivatives |
| 12/23/2009 | WO2009153536A1 1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists |
| 12/23/2009 | WO2009129408A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 12/23/2009 | WO2009125232A3 Herbal mix for treating upper respiratory diseases and pharmaceutical forms based thereon |
| 12/23/2009 | WO2009020534A3 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 12/23/2009 | WO2001000790A9 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 12/23/2009 | EP2135605A2 Therapeutic delivery of carbon monoxide |
| 12/23/2009 | EP1628634B1 Novel lipid mixtures for synthetic surfactants |
| 12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1356816B1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 12/23/2009 | EP1341538B1 Medicament compositions with salts of tiotropium and epinastin for the therapy of respiratory diseases |
| 12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/23/2009 | CN201365537Y Infant medicine bellyband |
| 12/23/2009 | CN101611015A Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 12/23/2009 | CN101611012A Cycloalkylamine substituted isoquinoline derivatives |
| 12/23/2009 | CN101610813A Quinuclidinol derivatives as muscarinic receptor antagonists |
| 12/23/2009 | CN101607960A Acebrophylline, surfolase and composition thereof |
| 12/23/2009 | CN101607082A Method for preparing inactivated vaccine of porcine reproductive and respiratory syndrome |
| 12/23/2009 | CN101607075A Oral solution capable of sweating and expelling toxin |
| 12/23/2009 | CN101607056A Method for curing senile wintercough by soaking feet in traditional Chinese medical liquid |
| 12/23/2009 | CN101607055A Method for curing cough by taking foot bath in traditional Chinese medicine solution |
| 12/23/2009 | CN101607054A Method for treating chronic trachitis among middle-aged population by soaking feet in Chinese medicament solution |
| 12/23/2009 | CN101607044A Method for curing head-eye vertigo by taking foot bath in traditional Chinese medicine solution |
| 12/23/2009 | CN101607035A Pharmaceutical composition for treating acute bronchitis in children |
| 12/23/2009 | CN101607034A Method for curing middle-aged asthma by soaking feet in traditional Chinese medical liquid |
| 12/23/2009 | CN101607033A Method for curing asthma by soaking feet in traditional Chinese medical liquid |
| 12/23/2009 | CN101607032A Compound medicament for treating children cough and preparation method thereof |
| 12/23/2009 | CN101607010A Method for treating cough due to wind-cold evil by soaking feet with traditional Chinese medicine |
| 12/23/2009 | CN101607009A Pharmaceutical composition for treating cold |
| 12/23/2009 | CN101607004A Separation and concentration method of drug extract liquid for preparing inflammation-diminishing and defervescing preparation |
| 12/23/2009 | CN101607001A Throat tablet for moisturizing and removing heat |
| 12/23/2009 | CN101606989A Novel preparation method of trollius chinensis granular preparation |
| 12/23/2009 | CN101606983A Method for curing cold by soaking feet in traditional Chinese medical liquid |
| 12/23/2009 | CN101606977A Preparation method and application of clove leaf total iridoid glycoside |
| 12/23/2009 | CN101606976A Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology |
| 12/23/2009 | CN101606975A Medicine for external use for treating rhinitis and preparation method thereof |
| 12/23/2009 | CN101606972A Method for curing influenza by taking foot bath in traditional Chinese medicine solution |
| 12/23/2009 | CN101606964A Veterinary traditional Chinese medical compound preparation |
| 12/23/2009 | CN101606962A Sugarless south isatis root granules and preparation method thereof |
| 12/23/2009 | CN101606960A Oral medicinal composition |
| 12/23/2009 | CN101606950A Pediatric paracetamol granule and quality control method |
| 12/23/2009 | CN101606946A Compound kanamycin sulfate injection liquid for pig and preparation method thereof |
| 12/23/2009 | CN101606931A Erdosteine composition and preparation method thereof |
| 12/23/2009 | CN101606903A Solution preparation for atomizing and inhaling ambroxol and preparation method thereof |
| 12/23/2009 | CN101606735A Health care beverage |
| 12/23/2009 | CN101606689A Health care beverage |
| 12/23/2009 | CN101606688A Health care beverage |
| 12/23/2009 | CN100572381C Pyrazolonaphthyridine derivative |
| 12/23/2009 | CN100571759C Spray agent containing traditional Chinese medicine for treating rhinitis, and its preparation method |
| 12/23/2009 | CN100571756C Chinese traditional medicine composition for treating influenza and quality controlling method and detection method thereof |
| 12/23/2009 | CN100571741C Chinese traditional medicine for treating aphonia and its preparation |
| 12/23/2009 | CA2727908A1 Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity |
| 12/23/2009 | CA2726746A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
| 12/23/2009 | CA2725481A1 Nicotinamide derivatives |
| 12/23/2009 | CA2725008A1 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 12/23/2009 | CA2724998A1 Nicotinamide derivatives |
| 12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
| 12/22/2009 | US7635774 Benzimidazole derivatives |
| 12/22/2009 | US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression |
| 12/22/2009 | US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid |
| 12/22/2009 | US7635490 Modified release dosage form |
| 12/22/2009 | CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn) |
| 12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/22/2009 | CA2414514C Carbamates derived from arylalkylamines |
| 12/22/2009 | CA2405593C Macrolides |
| 12/22/2009 | CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
| 12/22/2009 | CA2337571C Antihistamine leukotriene combinations |
| 12/22/2009 | CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide |
| 12/22/2009 | CA2307879C Treatment of t-helper cell type 2 mediated immune diseases |
| 12/17/2009 | WO2009152340A2 2,3-substituted thiophenes in lung inflammation therapies |
| 12/17/2009 | WO2009152171A1 Corticosteroid linked beta-agonist compounds for use in therapy |
| 12/17/2009 | WO2009152144A2 All day rhinitic condition treatment regimen |